Showing results (811-820 of 866) with videos related to
Sort By:
Pageof 87
ESMO Open|December 20, 2023
Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 studyJ Ajani, F El Hajbi, D Cunningham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphomaJ M Foran, A Z Rohatiner, D Cunningham, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 31, 2011
A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancerN Starling, F Vázquez-Mazón, D Cunningham, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2008
Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancerD Cunningham, B Sirohi, A Pluzanska, et al.Journal of Health Psychology|January 16, 2014
Effectiveness of a Screening and Brief Intervention protocol for heavy drinkers in dental practice: A cluster-randomized trialJames Alan Neff, Michelle L Kelley, Scott T Walters, et al.British Journal of Cancer|July 24, 2015
Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancerJ Rees, C N Hurt, S Gollins, et al.British Journal of Cancer|March 6, 2015
Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancerT J Price, M A Bruhn, C K Lee, et al.BMC Health Services Research|May 15, 2025
Evaluating a train-the-trainer approach for implementing obstetric life support in diverse healthcare contexts throughout Arizona: a mixed methods protocolShayna D Cunningham, Rogie Royce Carandang, Laurie S Wood, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2016
Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinomaS-E Al-Batran, E Van Cutsem, S C Oh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancerA Webb, D Cunningham, J H Scarffe, et al.Pageof 87